Brian C. Broderick’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$8.52M Buy
9,268
+1,052
+13% +$1.07M 1.57% 22
2025
Q4
$8.83M Buy
8,216
+720
+10% +$688K 1.67% 22
2025
Q3
$5.72M Buy
7,496
+985
+15% +$733K 1.09% 31
2025
Q2
$5.08M Buy
6,511
+999
+18% +$776K 1% 33
2025
Q1
$4.55M Buy
5,512
+2,832
+106% +$2.36M 0.93% 34
2024
Q4
$2.07M Sell
2,680
-48
-2% -$39.7K 0.41% 44
2024
Q3
$2.42M Sell
2,728
-24
-0.9% -$21.6K 0.47% 44
2024
Q2
$2.49M Buy
2,752
+207
+8% +$166K 0.51% 44
2024
Q1
$1.98M Buy
+2,545
New +$1.81M 0.42% 44
2021
Q4
Sell
-1,307
Closed -$303K 81
2021
Q3
$303K Sell
1,307
-50
-4% -$12.3K 0.08% 67
2021
Q2
$312K Hold
1,357
0.08% 67
2021
Q1
$253K Sell
1,357
-450
-25% -$88K 0.07% 69
2020
Q4
$306K Hold
1,807
0.09% 65
2020
Q3
$267K Sell
1,807
-125
-6% -$19.3K 0.09% 70
2020
Q2
$318K Hold
1,932
0.11% 70
2020
Q1
$268K Sell
1,932
-125
-6% -$17.2K 0.11% 71
2019
Q4
$271K Hold
2,057
0.09% 75
2019
Q3
$230K Hold
2,057
0.08% 79
2019
Q2
$228K Sell
2,057
-225
-10% -$26.5K 0.08% 78
2019
Q1
$296K Sell
2,282
-566
-20% -$68.8K 0.11% 70
2018
Q4
$330K Sell
2,848
-1,300
-31% -$145K 0.14% 67
2018
Q3
$446K Sell
4,148
-950
-19% -$95K 0.15% 69
2018
Q2
$435K Hold
5,098
0.16% 65
2018
Q1
$395K Hold
5,098
0.15% 69
2017
Q4
$431K Sell
5,098
-3,691
-42% -$314K 0.16% 67
2017
Q3
$752K Sell
8,789
-100
-1% -$8.2K 0.27% 62
2017
Q2
$732K Sell
8,889
-300
-3% -$24.5K 0.27% 64
2017
Q1
$773K Sell
9,189
-50
-0.5% -$4K 0.32% 58
2016
Q4
$680K Buy
9,239
+12
+0.1% +$894 0.29% 64
2016
Q3
$740K Hold
9,227
0.32% 60
2016
Q2
$726K Hold
9,227
0.31% 61
2016
Q1
$664K Buy
9,227
+700
+8% +$53K 0.29% 63
2015
Q4
$718K Buy
8,527
+4,015
+89% +$333K 0.32% 66
2015
Q3
$378K Buy
4,512
+12
+0.3% +$1.01K 0.18% 77
2015
Q2
$376K Sell
4,500
-100
-2% -$7.62K 0.16% 79
2015
Q1
$335K Hold
4,600
0.14% 82
2014
Q4
$317K Sell
4,600
-282
-6% -$19K 0.13% 82
2014
Q3
$317K Buy
4,882
+282
+6% +$17.9K 0.14% 86
2014
Q2
$286K Sell
4,600
-100
-2% -$5.97K 0.13% 86
2014
Q1
$276K Hold
4,700
0.14% 81
2013
Q4
$240K Hold
4,700
0.12% 85
2013
Q3
$236K Hold
4,700
0.13% 85
2013
Q2
$230K Buy
+4,700
New +$256K 0.14% 85

Other funds holding LLY

Brian C. Broderick's LLY Position: Q1 2026 in Review

Brian C. Broderick increased its Eli Lilly (LLY) stake by 13% in Q1 2026, buying an estimated $1.07M and bringing the position to 9,268 shares worth $8.52M. The position accounts for 1.57% of the portfolio, ranked #22.

Brian C. Broderick first reported a position in LLY in Q2 2013 and has held it in 43 quarters since. The position peaked at $8.83M in Q4 2025. 4,352 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Brian C. Broderick held 9,268 shares of Eli Lilly worth $8.52M as of Q1 2026.
  • Brian C. Broderick bought 1,052 Eli Lilly shares in Q1 2026, an estimated $1.07M.
  • Eli Lilly made up 1.57% of Brian C. Broderick's portfolio in Q1 2026, its #22 holding.
  • Brian C. Broderick first reported a position in Eli Lilly in Q2 2013 and has held it in 43 quarters since.
  • Brian C. Broderick's Eli Lilly position peaked at $8.83M in Q4 2025.
  • 4,352 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Brian C. Broderick's 13F filing for Q1 2026, filed 7 May 2026.